Published in Carcinogenesis on January 01, 2002
Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function. Mol Cell Biol (2005) 2.55
Inflammation and endothelial dysfunction during aging: role of NF-kappaB. J Appl Physiol (1985) (2008) 2.40
Nucleophosmin is required for DNA integrity and p19Arf protein stability. Mol Cell Biol (2005) 2.10
NPM1/B23: A Multifunctional Chaperone in Ribosome Biogenesis and Chromatin Remodeling. Biochem Res Int (2010) 1.49
Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation. Proc Natl Acad Sci U S A (2008) 1.44
Nucleophosmin and human cancer. Cancer Detect Prev (2006) 1.29
Ribosomal protein S9 is a novel B23/NPM-binding protein required for normal cell proliferation. J Biol Chem (2008) 1.24
Sumoylation of nucleophosmin/B23 regulates its subcellular localization, mediating cell proliferation and survival. Proc Natl Acad Sci U S A (2007) 1.22
Adeno-associated virus interactions with B23/Nucleophosmin: identification of sub-nucleolar virion regions. Virology (2006) 1.21
Nucleophosmin sets a threshold for p53 response to UV radiation. Mol Cell Biol (2004) 1.17
Nuclear but not cytosolic phosphoinositide 3-kinase beta has an essential function in cell survival. Mol Cell Biol (2011) 1.14
A proteomics approach for the identification of nucleophosmin and heterogeneous nuclear ribonucleoprotein C1/C2 as chromatin-binding proteins in response to DNA double-strand breaks. Biochem J (2005) 1.11
Increased expression of nucleophosmin/B23 in hepatocellular carcinoma and correlation with clinicopathological parameters. Br J Cancer (2007) 1.07
DNA damage, p14ARF, nucleophosmin (NPM/B23), and cancer. J Mol Histol (2006) 1.05
Nuclear Akt interacts with B23/NPM and protects it from proteolytic cleavage, enhancing cell survival. Proc Natl Acad Sci U S A (2008) 1.02
The Nucleolus Takes Control of Protein Trafficking Under Cellular Stress. Mol Cell Pharmacol (2010) 0.95
Long-term evolution and functional diversification in the members of the nucleophosmin/nucleoplasmin family of nuclear chaperones. Genetics (2006) 0.94
Dephosphorylation of nucleophosmin by PP1β facilitates pRB binding and consequent E2F1-dependent DNA repair. Mol Biol Cell (2010) 0.93
Identification of novel DNA-damage tolerance genes reveals regulation of translesion DNA synthesis by nucleophosmin. Nat Commun (2014) 0.83
Identification of proteins differentially expressed in adriamycin-resistant (pumc-91/ADM) and parental (pumc-91) human bladder cancer cell lines by proteome analysis. J Cancer Res Clin Oncol (2012) 0.83
Nucleophosmin contributes to the transcriptional activation function of the Epstein-Barr virus EBNA1 protein. J Virol (2013) 0.80
Ultraviolet C irradiation induces different expression of cyclooxygenase 2 in NIH 3T3 cells and A431 cells: the roles of COX-2 are different in various cell lines. Int J Mol Sci (2012) 0.78
Nucleophosmin: from structure and function to disease development. BMC Mol Biol (2016) 0.77
Expression and functional studies on the noncoding RNA, PRINS. Int J Mol Sci (2012) 0.77
Over Expression of Nucleophosmin and Nucleolin Contributes to the Suboptimal Activation of a G2/M Checkpoint in Ataxia Telangiectasia Fibroblasts. Mol Cell Pharmacol (2010) 0.77
Proteome analysis of proliferative response of bystander cells adjacent to cells exposed to ionizing radiation. Proteomics (2007) 0.77
Downregulation of NPM expression by Her-2 reduces resistance of gastric cancer to oxaliplatin. Oncol Lett (2017) 0.75
Histone displacement during nucleotide excision repair. Int J Mol Sci (2012) 0.75
Crosstalk between the nucleolus and the DNA damage response. Mol Biosyst (2017) 0.75
UV stimulation of nucleophosmin/B23 expression is an immediate-early gene response induced by damaged DNA. J Biol Chem (2002) 1.15
Involvement of nucleophosmin/B23 in the response of HeLa cells to UV irradiation. Int J Cancer (2002) 0.98
Valproic acid inhibits invasiveness in bladder cancer but not in prostate cancer cells. J Pharmacol Exp Ther (2006) 0.91
Nucleophosmin/B23 regulates PCNA promoter through YY1. Biochem Biophys Res Commun (2005) 0.84
Genetic association between germline JAK2 polymorphisms and myeloproliferative neoplasms in Hong Kong Chinese population: a case-control study. BMC Genet (2014) 0.77
Direct synthesis of Rev peptide-conjugated gold nanoparticles and their application in cancer therapeutics. Bioconjug Chem (2011) 0.75